Bernstein Remains Bullish On HCA Healthcare (HCA); Projects EBITDA Growth Of 2.8% and 4.6% in 2026 And 2027

Why It Matters

The price‑target reduction signals analyst caution that could affect investor sentiment, while the education acquisition positions HCA to address workforce shortages and diversify revenue streams.

Key Takeaways

• Bernstein lowers HCA price target to $413, cites valuation concerns.
• EBITDA projected to grow 2.8% in 2026, 4.6% in 2027.
• HCA acquires CHCP, adding 8,000+ Texas health‑care students.
• Acquisition expands HCA’s education footprint beyond nursing schools.
• Insurance policy changes and stagnant state payments pressure HCA earnings.

Pulse Analysis

HCA Healthcare operates a sprawling network of hospitals, urgent‑care centers and specialty clinics, making it a bellwether for U.S. health‑service earnings. Bernstein’s recent downgrade of the price target to $413, down from $503, reflects a cautious outlook amid tightening insurance coverage and flat state‑directed payments. While the analyst still rates the stock as Market Perform, the modest EBITDA forecasts—2.8% growth in 2026 and 4.6% in 2027—signal that earnings expansion will be incremental rather than transformational. Investors are therefore watching for any policy shift that could lift margins.

The acquisition of The College of Health Care Professions (CHCP) adds more than 8,000 students and ten Texas campuses to HCA’s growing education arm. By integrating an allied‑health training provider, HCA diversifies beyond its nursing colleges and creates a pipeline of technicians, sonographers and medical assistants—roles that are in chronic shortage nationwide. Retaining CHCP’s leadership under Chancellor Eric Bing ensures continuity while the deal leverages HCA’s clinical infrastructure for hands‑on training. This vertical integration could generate steady tuition revenue and reduce staffing gaps in HCA’s own facilities.

From a sector perspective, HCA’s dual focus on cost‑controlled operations and workforce development mirrors a broader industry trend toward self‑sufficiency. As insurers renegotiate reimbursement rates, hospitals that can staff positions internally stand to protect profit margins. Moreover, the education expansion positions HCA to capture a share of the $10 billion U.S. allied‑health education market, potentially offsetting earnings pressure from slower reimbursement growth. Analysts will likely monitor enrollment trends and regulatory approvals to gauge whether the strategic bet translates into measurable financial upside.